Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CLEVELAND, May 17, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Rodman and Renshaw 6th Annual Global Healthcare Conference, to be held May 16-18, 2010...
-
NEW YORK and CLEVELAND, May 14, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today presented data supporting its MultiStem® programs in cardiovascular disease, neurological disease and...
-
CLEVELAND, May 6, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended March 31, 2010. First Quarter and Recent Highlights...
-
CLEVELAND, April 29, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter financial results at approximately 4:00 p.m. Eastern Time (ET) on Thursday,...
-
CLEVELAND, April 20, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will host its second annual Investor/Research & Development Day being held at the Intercontinental...
-
CLEVELAND, March 11, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter of 2009 and for the year ended December 31, 2009. Fourth...
-
CLEVELAND, Feb. 25, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its fourth quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday,...
-
CLEVELAND, Feb. 16, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has completed patient enrollment for its phase I clinical trial of MultiStem®, its allogeneic...
-
CLEVELAND, Feb. 10, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their...
-
CLEVELAND, Feb. 2, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will present at the 12th Annual BIO CEO & Investor Conference to be held at the Waldorf-Astoria...